DBX2 antisense RNA 1 (DBX2-AS1)

DBX2 antisense RNA 1 (DBX2-AS1) is a long non-coding RNA (lncRNA) gene transcribed antisense to the DBX2 coding gene. As an lncRNA, it is not translated into a functional protein and is part of a broad class of non-coding RNAs involved in the regulation of gene expression through mechanisms such as chromatin modification, recruitment of transcription factors, modulation of splicing, and control of mRNA stability[1][3][5]. DBX2-AS1 does not currently have a characterized function or disease association in the literature or gene databases, nor is it identified as an established therapeutic target[5]. Antisense lncRNAs as a class are increasingly studied for their roles in gene regulation and pathology (notably cancer), but DBX2-AS1 itself is not listed among those with known impact in such disease roles in current major transcriptomic cancer studies[2][4]. No drugs are known to interact directly with DBX2-AS1, and it is not used as a biomarker. Key points: - DBX2-AS1 is a long non-coding antisense RNA gene. - No current evidence supports its role as a therapeutic target. - It fits the broad classification of regulatory antisense lncRNAs but has no specifically described biological or disease functions. - There are no known interacting drugs, mechanisms of action, or safety concerns related to DBX2-AS1. Note: Do not confuse DBX2-AS1 with other well-studied antisense RNAs such as CDKN2B-AS1 or disease-linked lncRNAs such as HOTAIR or ANRIL[3][7].

Other names

NCBI Gene: 120766145Ensembl: ENSG00000257319HGNC:55479

Not applicable (not a known direct therapeutic target)